Streetbeat News

Stock Prices

ROK

Rockwell Automation's (NYSE:ROK) short percent of float has fallen 6.38% since its last report, with 3.12 million shares sold short, which is 3.08% of all regular shares available for trading. It would take traders 4.58 days to cover their short positions on average. The company's short interest is less than its peer group average of 10.68%.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:15 pm

ZTS

Zoetis's (NYSE:ZTS) short percent of float has risen 26.67% since its last report, with 3.51 million shares sold short, which is 0.76% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. However, compared to its peers, Zoetis has less short interest as a percentage of float, which is 4.42% on average.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:15 pm

NIO

NIO shares are trading higher after the company reportedly implemented measures to boost production of the ES6 following a brief five-day hiatus.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 6:10 pm

AAPL

AMZN

NVDA

SFTBF

Arm Ltd, owned by Softbank Group Corp, is preparing to file for a Nasdaq IPO, with a potential valuation of $60 billion - $70 billion. The company is expected to raise $8 billion - $10 billion. Investors are keen to understand how Arm plans to diversify beyond its mobile-chip designs, which have been used by Apple Inc and Amazon.com Inc. Despite CEO Masayoshi Son's optimism about Arm's role in the AI boom, some analysts remain skeptical. Nvidia Corp has emerged as the prime beneficiary of the AI surge, but Arm could potentially collaborate with Nvidia due to its energy-efficient CPUs.

Portfolio Pulse from Anusuya Lahiri

August 21, 2023 | 6:01 pm

MELI

A significant number of investors have taken a bearish stance on MercadoLibre (NASDAQ:MELI), with 52% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $900.0 to $1700.0 for MercadoLibre over the last 3 months. The price of MELI is up 0.95% at $1211.0. Several financial institutions including Credit Suisse, JP Morgan, Goldman Sachs, and Barclays have maintained their positive ratings on MercadoLibre.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:01 pm

TMUS

A significant bearish stance has been taken on T-Mobile US (NASDAQ:TMUS) by a large investor, as observed from publicly available options history. The overall sentiment of these big-money traders is split between 27% bullish and 72% bearish. The whales have been targeting a price range from $65.0 to $165.0 for T-Mobile US over the last 3 months. RBC Capital, TD Cowen, and Morgan Stanley have maintained their positive ratings on T-Mobile US, while Benchmark has downgraded its action to Buy.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:01 pm

DVN

A significant bearish stance has been taken on Devon Energy (NYSE:DVN) by a large investor, as indicated by unusual options trades. The sentiment among these big-money traders is split, with 40% bullish and 60% bearish. The whales have been targeting a price range from $50.0 to $65.0 for Devon Energy over the last 3 months. Several financial institutions have maintained their ratings on Devon Energy, with price targets ranging from $55 to $77.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:01 pm

CHDN

Churchill Downs (NASDAQ:CHDN) has received 10 analyst ratings in the last quarter, with 3 being bullish and 7 somewhat bullish. The average price target is $153.6, implying an upside from the current price of $123.88. This average has decreased by 2.78% from the previous average price target of $158.00.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:00 pm

NEO

In the last quarter, NeoGenomics (NASDAQ:NEO) received 2 bullish, 1 somewhat bullish, and 1 indifferent rating from analysts. The company's average 12-month price target is $18.75, which has increased by 2.29% over the past month.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:00 pm

WST

Over the past three months, four analysts have published their opinions on West Pharmaceutical Servs (NYSE:WST) stock, with one being bullish and three somewhat bullish. The average price target is $406.25, implying an upside from the current price of $393.025. The average price target has increased by 4.84% over the past month.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:00 pm